Cutting edge: Fas ligand (CD178) cytoplasmic tail is a positive regulator of Fas ligand-mediated

被引:10
|
作者
Jodo, S
Pidiyar, VJ
Xiao, S
Furusaki, A
Sharma, R
Koike, T
Ju, ST [1 ]
机构
[1] Univ Virginia, Dept Internal Med, Div Rheumatol & Immunol, Charlottesville, VA 22908 USA
[2] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido, Japan
来源
JOURNAL OF IMMUNOLOGY | 2005年 / 174卷 / 08期
关键词
D O I
10.4049/jimmunol.174.8.4470
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cytotoxic function of CD178 (Tas ligand (FasL)) is critical to the maintenance of peripheral tolerance and immune-mediated tissue pathology. The active site of FasL resides at the FasL extracellular region (FasL(Ext)) and it functions through binding/cross-linking Fas receptor on target cells. In this study, we report that FasL(Ext)-mediated cytotoxicity is regulated by the FasL cytoplasmic tail (Fas(LCyt)). Deleting the N-terminal 2-70 aa (Delta 70) or N-terminal 2-33 aa (Delta 33) reduced the cytotoxic strength as much as 30- to 100-fold. By contrast, change in the cytotoxic strength was not observed with FasL deleted of the proline-rich domains (45-74 aa, Delta PRD) in the FasL(Cyt) Our study identifies a no velfunction of FasL(Cyt) and demonstrates that FasL(Cyt), a sequence unique to FasL, is critically required for the optimal expression of FasL(Ext)-mediated cytotoxicity.
引用
收藏
页码:4470 / 4474
页数:5
相关论文
共 50 条
  • [21] Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis
    Hodgson, PD
    Grant, MD
    Michalak, TI
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 118 (01): : 63 - 70
  • [22] Resistance to Fas/Fas ligand-mediated apoptosis and expression of survival proteins on lung fibroblasts
    Tanaka, T
    Hagimoto, N
    Maeyama, T
    Miyazaki, H
    Kunitake, R
    Kawasaki, M
    Matsuba, T
    Kuwano, K
    Hara, N
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A197 - A197
  • [23] The critical role of protein kinase C-θ in Fas/Fas ligand-mediated apoptosis
    Manicassainy, Santhakumar
    Sun, Zuoming
    JOURNAL OF IMMUNOLOGY, 2007, 178 (01): : 312 - 319
  • [24] Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption
    Choi, HJ
    Ku, JK
    Kim, MY
    Kang, H
    Cho, SH
    Kim, HO
    Park, YM
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (03) : 419 - 425
  • [25] Fas ligand-mediated keratinocyte apoptosis in fixed drug eruption
    Park, Y
    Choi, H
    Ku, J
    Kim, M
    Kim, H
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A12 - A12
  • [26] Soluble Fas ligand-mediated apoptosis of human osteoblasts.
    Kawakami, A
    Eguchi, K
    Matsuoka, N
    Tsuboi, M
    Urayama, S
    Kawabe, Y
    Fujiyama, K
    Kiriyama, T
    Nagataki, S
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 295 - 295
  • [27] Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells
    Sun, SY
    Yue, P
    Hong, WK
    Lotan, R
    CANCER RESEARCH, 2000, 60 (22) : 6537 - 6543
  • [28] Regulation of Fas/Fas Ligand-Mediated Apoptosis in Megakaryocytes by Nuclear Factor of Activated T Cells
    Arabanian, Laleh S.
    Kyttaelae, Satu
    Habermann, Ivonne
    Ehninger, Gerhard
    Kiani, Alexander
    BLOOD, 2009, 114 (22) : 1544 - 1544
  • [29] CD4(+) T cells kill CD8(+) T cells via Fas/Fas ligand-mediated apoptosis
    Piazza, C
    Gilardini Montani, MS
    Moretti, S
    Cundari, E
    Piccolella, E
    JOURNAL OF IMMUNOLOGY, 1997, 158 (04): : 1503 - 1506
  • [30] Fas-Fas ligand-mediated apoptosis in the serum of patients with ocular cicatricial pemphigold.
    Gion, NM
    Foster, CS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S372 - S372